Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment

Acta Haematologica

Volumn 98, Issue 3, 1997, Pages 140-146

  Aizawa, Shin ^a   Nakano, Masaru ^b   Yaguchi, Makoto ^b   Kuriyama, Yuzuru ^b   Iwase, Osamu ^b   Toyama, Keisuke ^b   Tanaka, Kiyoshi ^a   Hoshi, Hajime ^a   Sugimoto, Kotaro ^c   Kaido, Akihiro ^c   Imai, Takeshi ^c   Nabeshima, Ryusuke ^c   Handa, Hiroshi ^c  

^a NIHON UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Agranulocytosis; Bone marrow stromal cell; CD34; Cytokine; Granulopoiesis; Long term bone marrow culture; Vesnarinone

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PIPERANOMETOZINE;

AGRANULOCYTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; STROMA CELL;

AGRANULOCYTOSIS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; COLONY-FORMING UNITS ASSAY; CYTOKINES; HUMANS; QUINOLINES; STROMAL CELLS;

EID: 0030870476     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203608     Document Type: Article

References (23)

1. Schocken DD. Arrieta MI, Leaverton PH, Ross EA: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306.
2. Franciosa JA, Wilen M, Zicschc S, Cohn JN: Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-836.
3. Inouc M, Kim BH. Hori M. Tsuneoka Y. Mat-subara N, Kamada T, Kodama K, Naka M, Nanto S, Higashino Y: Oral OPC-8212 for the treatment of congestive heart failure: Hemodynamic improvement and increased exercise capacity. Heart Vessels 1986;2:166-171.
4. OPC-8218 Multicenter Research Group: A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. Cardiovasc Drugs and Ther 1990;4:419-423.
5. Feldman AM, Baughman KE, Lee WK, Gottlieb SH. Weiss JL, Becker LC, Strobeck JE: Usefulness of OPC-8212, quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1203-1210.
6. Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix DGE, Powers ER, Bain RP. White BG: Effects of vesnarinone on mortality in patients with heart failure. N Engl J Med 1993; 329:149-155.
7. Hori M, Inoue M, Tamai J, Koretsune Y, Kita-kaze M, Iwai K, Iwakura K, Kitabatakc A, Kamada T: Beneficial effect of OPC-8212 (3,4-dihydro-6- [4-(3,4-dcmethoxybenzoyl)-l-piper-azinyl] -2(lH)-quinolinone) on myocardial oxygen consumption in dogs with ischemic heart failure. Jpn J Pharmacol 1986;50:659-665.
8. Taira N, Endoh M, Iijima T, Satoh K, Yanagis-awa T, Yamashita S, Maruyama M, Kawada M, Morita T, Wada T: Mode and Mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxy-benzoyl)-1 -piperazinyl]-2(1 H)-quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart. Arzncimittelforschung 1984; 34:347-356.
9. Saito K, Waga K, Yamato R, Enokihara H, Furusawa S, Shishido H, Hayashida T: Vcsnar-inone induced agranulocytosis. Am J Hematol 1993;44:217-218.
10. Aizawa S, Yaguchi M, Nakano M, Toyama K, Inokuchi S, Imai T, Yasuda M, Nabeshima R, Handa H: Hemopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol 1994;22:482-487.
11. Dexter TM. Spooncer E. Varga J, Allen TD, Lanotte M: Haemopoietic stem cells; in Kill-mann EP. Cronkite EP. Muller-Bcrt CN (eds): Alfred Benzon Symposium 18 Sv-Aa. Copenhagen, Munksgaard, 1983, pp 303-318.
12. Izumi H, Miyanomae T, Tsurusawa M, Fujita J, Mori KJ: Effect of bacterial lipopolysaccha-ride and x-irradiation on the production of colony-stimulating factor and maintenance of granulopoiesis in bone marrow culture. Leuk Res 1984;8:295-305.
13. Heard J, Fishekson S, Varet B: Role of colony-stimulating activity in murine long-term bone marrow cultures: evidence for its production and comsumption by the adherent cells. Blood 1982;59:761-767.
14. Schofield R: The relationship between the spleen colony forming cell and hemopoietic stem cell. A hypothesis. Blood Cell 1978;4:7-25.
15. Aizawa S, Tavassoli M: In vitro homing of hematopoietic stem cells is mediated by recognition system with galactosyl and mannosyl specificities. Proc Natl Acad Sci USA 1987:84: 4485-4489.
16. Ohkawa H, Harigaya K: Effect of direct cell-to-ccll interaction between the KM-102 clonal human marrow stromal cell line and HL-60 myeloid leukemic cell line on the differentiation and proliferation of the HL-60 line. Cancer Res 1987;47:2879-2882.
17. Wolf NS, Trentin JJ: Hemopoietic colony studies. V. Effect of hemopoietic organ stroma on differentiation of pluripotent stem cells. J Exp Med 1986;127:205-214.
18. Tavasolli M, Friedenstein A: Hemopoietic microenvironment. Am J Hematol 1983; 15:195-203.
19. Aizawa S, Yaguchi M. Nakano M, Inokuchi S, Handa H, Toyama K: Establishment of a variety of human bone marrow stromal cell lines by the recombinant SV40-adenovirus vector. J Cell Physiol 1991;148:245-251.
20. Ohnishi A, Ishizaki T: Pharmacokinetic profile of OPC-8212 in humans: A new, nonglycosidic, inotropic agent. J Clin Pharmacol 1988;28: 719-726.
21. Golde DW, Beizer MB: Neutropenia and agranulocytosis; in Lichtman MA (ed): Hematology and Oncology. New York, Grune &Stratton, 1988, pp 126-138.
22. Neftel KA, Hauser SP, Muller MR: Inhibition of granulopoiesis in vivo and in vitro by ß-lac-tam antibiotics. J Infect Dis 1985:152:90-98.
23. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S: Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated blood from patients with heart failure. Circulation 1994;89:955-958.